{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:04:07Z","timestamp":1789718647336,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.toxicon.2023.107587","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T11:24:41Z","timestamp":1703244281000},"page":"107587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of therapeutic benefits of botulinum toxin for foot dystonia associated with Parkinson's disease"],"prefix":"10.1016","volume":"238","author":[{"given":"Ping","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-qian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-feng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0224-1700","authenticated-orcid":false,"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2023.107587_bib1","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2147\/CIA.S115304","article-title":"Calf-raise senior: a new test for assessment of plantar flexor muscle strength in older adults: protocol, validity, and reliability","volume":"11","author":"Andr\u00e9","year":"2016","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.toxicon.2023.107587_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1474-4422(05)70119-8","article-title":"Striatal deformities of the hand and foot in Parkinson's disease","volume":"4","author":"Ashour","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxicon.2023.107587_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/cjn.2017.245","article-title":"Botulinum toxin type A for pain in advanced Parkinson's disease","volume":"45","author":"Bruno","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.toxicon.2023.107587_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gaitpost.2018.02.026","article-title":"The relationship between foot posture and plantar pressure during walking in adults: a systematic review","volume":"62","author":"Buldt","year":"2018","journal-title":"Gait Posture"},{"key":"10.1016\/j.toxicon.2023.107587_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0021-9290(87)90255-7","article-title":"The arch index: a useful measure from footprints","volume":"20","author":"Cavanagh","year":"1987","journal-title":"J. Biomech."},{"key":"10.1016\/j.toxicon.2023.107587_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clineuro.2016.02.003","article-title":"Frequency and clinical correlates of postural and striatal deformities in Parkinson's disease","volume":"142","author":"Cervantes-Arriaga","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.toxicon.2023.107587_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10120532","article-title":"Spatiotemporal gait analysis and lower limb functioning in foot dystonia treated with botulinum toxin","volume":"10","author":"Datta Gupta","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107587_bib8","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jelekin.2013.05.011","article-title":"Assessment of the activation modalities of gastrocnemius lateralis and tibialis anterior during gait: a statistical analysis","volume":"23","author":"Di Nardo","year":"2013","journal-title":"J. Electromyogr. Kinesiol."},{"key":"10.1016\/j.toxicon.2023.107587_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13060428","article-title":"Efficacy and optimal dose of botulinum toxin A in post-stroke lower extremity spasticity: a systematic review and meta-analysis","volume":"13","author":"Doan","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107587_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00702-020-02266-z","article-title":"Botulinum toxin therapy of dystonia","volume":"128","author":"Dressler","year":"2021","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.toxicon.2023.107587_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/cjn.2021.42","article-title":"Effects of onabotulinum toxin A on gait in Parkinson's disease patients with foot dystonia","volume":"49","author":"Huang","year":"2022","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.toxicon.2023.107587_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15020081","article-title":"Botulinum toxin treatment of motor disorders in Parkinson disease-A systematic review","volume":"15","author":"Jabbari","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107587_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12100646","article-title":"Ankle and foot spasticity patterns in chronic stroke survivors with abnormal gait","volume":"12","author":"Li","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107587_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2017.04.006","article-title":"Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases","volume":"40","author":"Malek","year":"2017","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.toxicon.2023.107587_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10072-005-0378-9","article-title":"A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot","volume":"26","author":"Mancini","year":"2005","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.toxicon.2023.107587_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9090260","article-title":"Botulinum toxin for the treatment of neuropathic pain","volume":"9","author":"Park","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107587_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF03022619","article-title":"The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain","volume":"53","author":"Park","year":"2006","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.toxicon.2023.107587_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2017.10.009","article-title":"Incobotulinum toxin A in Parkinson's disease with foot dystonia: a double blind randomized trial","volume":"46","author":"Rieu","year":"2018","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.toxicon.2023.107587_bib19","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.clinph.2013.02.006","article-title":"Persons with Parkinson's disease exhibit decreased neuromuscular complexity during gait","volume":"124","author":"Rodriguez","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.toxicon.2023.107587_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.gaitpost.2021.04.019","article-title":"Differences in predictors for gait speed and gait endurance in Parkinson's disease","volume":"87","author":"Shearin","year":"2021","journal-title":"Gait Posture"},{"key":"10.1016\/j.toxicon.2023.107587_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.05.001","article-title":"Dystonia and Parkinson's disease: what is the relationship?","volume":"132","author":"Shetty","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.toxicon.2023.107587_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.parkreldis.2011.08.002","article-title":"Assessing the utility of freezing of gait questionnaires in Parkinson's disease","volume":"18","author":"Shine","year":"2012","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.toxicon.2023.107587_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/NPT.0000000000000244","article-title":"Lower extremity muscle strength and force variability in persons with Parkinson disease","volume":"43","author":"Skinner","year":"2019","journal-title":"J. Neurol. Phys. Ther."},{"key":"10.1016\/j.toxicon.2023.107587_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2021.110874","article-title":"Muscle actions on crossed and non-crossed joints during upright standing and gait: a comprehensive description based on induced acceleration analysis","volume":"130","author":"Souza","year":"2022","journal-title":"J. Biomech."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123003987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123003987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:25:21Z","timestamp":1758576321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010123003987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":24,"alternative-id":["S0041010123003987"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107587","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of therapeutic benefits of botulinum toxin for foot dystonia associated with Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107587"}}